2Indexed trials
drug · Product Intelligence
Deferiprone
Pipeline Intelligence
Deferiprone: 2 indexed trials, 2 sponsors; 7 linked Orange Book patents and 15 FDA-linked events where matched.
2Sponsors
7Orange Book patent links
15FDA-linked events
Development evidence
NCT00907283Ente Ospedaliero Ospedali Galliera · other_neurologyPHASE2
NCT00943748University Hospital, Lille · parkinsonsPHASE2, PHASE3
FDA / patent evidence
10780055FERRIPROX · app 2122692038-10-25
10940115FERRIPROX · app 2122692038-10-25
10940116FERRIPROX · app 2122692038-10-25
11357731FERRIPROX · app 2122692038-10-25
11458103FERRIPROX · app 2122692038-10-25
11723874FERRIPROX · app 2122692038-10-25
8703156FERRIPROX · app 2080302029-10-26
Regulatory context
FDA_EXCLUSIVITYFERRIPROX · ODE-4212028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4212028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4172028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4182028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4192028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4172028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4202028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4172028-04-30
FDA_EXCLUSIVITYFERRIPROX · ODE-4202028-04-30
FDA_APPROVALDEFERIPRONE · 2025-12-11
FDA_APPROVALDEFERIPRONE · 2022-02-08
FDA_APPROVALFERRIPROX · 2020-05-19
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.